Literature DB >> 28688235

HIV-Associated Cardiovascular Disease: Role of Connexin 43.

Lisa Prevedel1, Camilla Morocho1, Michael V L Bennett2, Eliseo A Eugenin3.   

Abstract

Chronic HIV infection due to effective antiretroviral treatment has resulted in a broad range of clinical complications, including accelerated heart disease. Individuals with HIV infection have a 1.5 to 2 times higher incidence of cardiovascular diseases than their uninfected counterparts; however, the underlying mechanisms are poorly understood. To explore the link between HIV infection and cardiovascular diseases, we used postmortem human heart tissues obtained from HIV-infected and control uninfected individuals to examine connexin 43 (Cx43) expression and distribution and HIV-associated inflammation. Here, we demonstrate that Cx43 is dysregulated in the hearts of HIV-infected individuals. In all HIV heart samples analyzed, there were areas where Cx43 was overexpressed and found along the lateral membrane of the cardiomyocyte and in the intercalated disks. Areas of HIV tissue with anomalous Cx43 expression and localization also showed calcium overload, sarcofilamental atrophy, and accumulation of collagen. All these changes were independent of viral replication, CD4 counts, inflammation, and type of antiretroviral treatment. Overall, we propose that HIV infection increases Cx43 expression in heart, resulting in tissue damage that likely contributes to the high rates of cardiovascular disease in HIV-infected individuals.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28688235      PMCID: PMC5809504          DOI: 10.1016/j.ajpath.2017.05.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

Review 1.  Functional consequences of abnormal Cx43 expression in the heart.

Authors:  Magda S C Fontes; Toon A B van Veen; Jacques M T de Bakker; Harold V M van Rijen
Journal:  Biochim Biophys Acta       Date:  2011-08-03

2.  Distribution and three-dimensional structure of intercellular junctions in canine myocardium.

Authors:  R H Hoyt; M L Cohen; J E Saffitz
Journal:  Circ Res       Date:  1989-03       Impact factor: 17.367

3.  [Cardiac side effects of anti-HIV agents].

Authors:  J J Monsuez; B Gallet; L Escaut; F Vayre; M Pulik; J C Charniot; M Merad; M Slama; S Weber; D Vittecoq
Journal:  Arch Mal Coeur Vaiss       Date:  2000-07

4.  HIV-1-Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema.

Authors:  Ntobeko Ntusi; Eoin O'Dwyer; Lucy Dorrell; Emma Wainwright; Stefan Piechnik; Genevieve Clutton; Gemma Hancock; Vanessa Ferreira; Pete Cox; Motasim Badri; Theodoros Karamitsos; Sam Emmanuel; Kieran Clarke; Stefan Neubauer; Cameron Holloway
Journal:  Circ Cardiovasc Imaging       Date:  2016-03       Impact factor: 7.792

Review 5.  New aspects of pathogenesis of atrial fibrillation: remodelling of intercalated discs.

Authors:  N Tribulova; T Egan Benova; B Szeiffova Bacova; C Viczenczova; M Barancik
Journal:  J Physiol Pharmacol       Date:  2015-10       Impact factor: 3.011

6.  Coronary heart disease in HIV-infected individuals.

Authors:  Judith S Currier; Anne Taylor; Felicity Boyd; Christopher M Dezii; Hugh Kawabata; Beth Burtcel; Jen-Fue Maa; Sally Hodder
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

7.  Calcified mitochondria in epithelial cells of the respiratory tract in upper respiratory thermal injury.

Authors:  R Drut
Journal:  Diagn Cytopathol       Date:  1998-10       Impact factor: 1.582

8.  Vascular dysfunction and cardiovascular complications.

Authors:  Virginia A Triant; Steven K Grinspoon
Journal:  Curr Opin HIV AIDS       Date:  2007-07       Impact factor: 4.283

9.  Infection of the heart by the human immunodeficiency virus.

Authors:  W W Grody; L Cheng; W Lewis
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

10.  Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: detection by multiplex, nested, polymerase chain reaction in individually microdissected cells from right ventricular endomyocardial biopsy tissue.

Authors:  E R Rodriguez; S Nasim; J Hsia; R L Sandin; A Ferreira; B A Hilliard; A M Ross; C T Garrett
Journal:  Am J Cardiol       Date:  1991-12-01       Impact factor: 2.778

View more
  6 in total

1.  A descriptive, cross-sectional study examining treatment burden in people living with HIV.

Authors:  Nathanial Schreiner; Joseph Perazzo; Jackson Currie; Barbra Daly; Allison Webel
Journal:  Appl Nurs Res       Date:  2019-02-13       Impact factor: 2.257

2.  HIV infection of astrocytes compromises inter-organelle interactions and inositol phosphate metabolism: A potential mechanism of bystander damage and viral reservoir survival.

Authors:  Shaily Malik; Silvana Valdebenito; Daniela D'Amico; Brendan Prideaux; Eliseo A Eugenin
Journal:  Prog Neurobiol       Date:  2021-08-26       Impact factor: 11.685

Review 3.  Intercalated discs: cellular adhesion and signaling in heart health and diseases.

Authors:  Guangze Zhao; Ye Qiu; Huifang M Zhang; Decheng Yang
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

4.  HIV infection and latency induce a unique metabolic signature in human macrophages.

Authors:  Paul Castellano; Lisa Prevedel; Silvana Valdebenito; Eliseo A Eugenin
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

5.  Tunneling nanotubes (TNT) mediate long-range gap junctional communication: Implications for HIV cell to cell spread.

Authors:  George Okafo; Lisa Prevedel; Eliseo Eugenin
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

Review 6.  HIV-1 Tat: Role in Bystander Toxicity.

Authors:  David Ajasin; Eliseo A Eugenin
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.